These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Precision therapy for acute myeloid leukemia. Yang X; Wang J J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553 [TBL] [Abstract][Full Text] [Related]
3. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions. DiNardo C; Lachowiez C Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639 [TBL] [Abstract][Full Text] [Related]
4. Acute Myeloid Leukemia: A Review. Pelcovits A; Niroula R R I Med J (2013); 2020 Apr; 103(3):38-40. PubMed ID: 32236160 [TBL] [Abstract][Full Text] [Related]
5. Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia. Ma J; Ge Z Bosn J Basic Med Sci; 2021 Aug; 21(4):409-421. PubMed ID: 33577442 [TBL] [Abstract][Full Text] [Related]
12. Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy. Sami SA; Darwish NHE; Barile ANM; Mousa SA Curr Treat Options Oncol; 2020 Jan; 21(1):3. PubMed ID: 31933183 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia. Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999 [TBL] [Abstract][Full Text] [Related]
14. Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus. Montesinos P; Bergua J; Infante J; Esteve J; Guimaraes JE; Sierra J; Sanz MÁ Ann Hematol; 2019 Nov; 98(11):2467-2483. PubMed ID: 31667544 [TBL] [Abstract][Full Text] [Related]